These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23399156)

  • 1. A review of polysaccharide cytotoxic drug conjugates for cancer therapy.
    Goodarzi N; Varshochian R; Kamalinia G; Atyabi F; Dinarvand R
    Carbohydr Polym; 2013 Feb; 92(2):1280-93. PubMed ID: 23399156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEG conjugates in clinical development or use as anticancer agents: an overview.
    Pasut G; Veronese FM
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1177-88. PubMed ID: 19671438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer polysaccharides from natural resources: a review of recent research.
    Zong A; Cao H; Wang F
    Carbohydr Polym; 2012 Nov; 90(4):1395-410. PubMed ID: 22944395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugates.
    Strop P; Liu SH; Dorywalska M; Delaria K; Dushin RG; Tran TT; Ho WH; Farias S; Casas MG; Abdiche Y; Zhou D; Chandrasekaran R; Samain C; Loo C; Rossi A; Rickert M; Krimm S; Wong T; Chin SM; Yu J; Dilley J; Chaparro-Riggers J; Filzen GF; O'Donnell CJ; Wang F; Myers JS; Pons J; Shelton DL; Rajpal A
    Chem Biol; 2013 Feb; 20(2):161-7. PubMed ID: 23438745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in tumor-targeting anticancer drug conjugates.
    Jaracz S; Chen J; Kuznetsova LV; Ojima I
    Bioorg Med Chem; 2005 Sep; 13(17):5043-54. PubMed ID: 15955702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-protein and polymer-drug conjugates in cancer therapy.
    Thanou M; Duncan R
    Curr Opin Investig Drugs; 2003 Jun; 4(6):701-9. PubMed ID: 12901229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and development of polymer conjugates as anti-angiogenic agents.
    Segal E; Satchi-Fainaro R
    Adv Drug Deliv Rev; 2009 Nov; 61(13):1159-76. PubMed ID: 19699248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles for delivery of chemotherapeutic agents to tumors.
    Vijayaraghavalu S; Raghavan D; Labhasetwar V
    Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer conjugates: nanosized medicines for treating cancer.
    Vicent MJ; Duncan R
    Trends Biotechnol; 2006 Jan; 24(1):39-47. PubMed ID: 16307811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
    Maeda H; Bharate GY; Daruwalla J
    Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor polysaccharides from mushrooms: a review on the structural characteristics, antitumor mechanisms and immunomodulating activities.
    Meng X; Liang H; Luo L
    Carbohydr Res; 2016 Apr; 424():30-41. PubMed ID: 26974354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles.
    Wong HL; Bendayan R; Rauth AM; Li Y; Wu XY
    Adv Drug Deliv Rev; 2007 Jul; 59(6):491-504. PubMed ID: 17532091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymer-drug conjugates: towards a novel approach for the treatment of endrocine-related cancer.
    Duncan R; Vicent MJ; Greco F; Nicholson RI
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S189-99. PubMed ID: 16113096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based targeted therapy for cancer tissue.
    Das M; Mohanty C; Sahoo SK
    Expert Opin Drug Deliv; 2009 Mar; 6(3):285-304. PubMed ID: 19327045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Anionic Polysaccharides in the Preparation of Nanomedicines with Anticancer Applications.
    Martínez AM; Benito M; Pérez E; María Teijón J; Dolores Blanco M
    Curr Pharm Des; 2016; 22(22):3364-79. PubMed ID: 26818877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal mushroom modulators of molecular targets as cancer therapeutics.
    Zaidman BZ; Yassin M; Mahajna J; Wasser SP
    Appl Microbiol Biotechnol; 2005 Jun; 67(4):453-68. PubMed ID: 15726350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.